MARKET

PCRX

PCRX

Pacira BioSciences Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

32.58
+0.36
+1.12%
Closed 16:00 04/02 EDT
OPEN
32.35
PREV CLOSE
32.22
HIGH
33.22
LOW
31.40
VOLUME
501.11K
TURNOVER
--
52 WEEK HIGH
51.35
52 WEEK LOW
27.46
MARKET CAP
1.37B
P/E (TTM)
-122.5273
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PCRX stock price target is 56.23 with a high estimate of 85.00 and a low estimate of 44.00.

EPS

PCRX News

More
  • FDA accepts Innocoll application for post-surgical pain implant
  • Seeking Alpha - Article · 03/26 17:10
  • Pacira (PCRX) Down 37.2% Since Last Earnings Report: Can It Rebound?
  • Zacks · 03/21 16:30
  • Piper Sandler likes Gilead ahead of expected FDA nod for remdesivir for Covid-19
  • Seeking Alpha - Article · 03/20 11:12
  • The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment
  • Benzinga · 03/17 15:38

Industry

Pharmaceuticals
+2.64%
Pharmaceuticals & Medical Research
+2.79%

Hot Stocks

Symbol
Price
%Change

About PCRX

Pacira BioSciences, Inc., formerly Pacira Pharmaceuticals, Inc. is a holding company. The Company is a pharmaceutical company focused on the development, manufacture and commercialization of pharmaceutical products, based on its DepoFoam extended release drug delivery technology, for use primarily in hospitals and ambulatory surgery centers. Its lead product candidate is EXPAREL (bupivacaine liposome injectable suspension), which consists of bupivacaine, an amide-type local anesthetic, encapsulated in DepoFoam and is indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. In addition to EXPAREL, DepoFoam is also the basis for its other Food and Drug Administration-approved commercial product, DepoCyt(e), which it manufactures for its commercial partners, as well as its product candidates. The Company's other product candidates include DepoMeloxicam (DepoMLX) and DepoTranexamic Acid (DepoTXA).
More

Webull offers kinds of Pacira Biosciences Inc stock information, including NASDAQ:PCRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PCRX stock news, and many more online research tools to help you make informed decisions.